BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11860313)

  • 1. Extranodal posttransplant plasmacytic hyperplasia with subsequent posttransplant plasmacytic malignancy: six-year interval case report and review of the literature.
    Dunphy CH; Galambos C; Polski JM; Evans HL; Gardner LJ; Grosso LE; Montone KT
    Arch Pathol Lab Med; 2002 Mar; 126(3):351-6. PubMed ID: 11860313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric immunophenotyping in posttransplant lymphoproliferative disorders.
    Dunphy CH; Gardner LJ; Grosso LE; Evans HL
    Am J Clin Pathol; 2002 Jan; 117(1):24-8. PubMed ID: 11789726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric evaluation of posttransplant B-cell lymphoproliferative disorders.
    Kaleem Z; Hassan A; Pathan MH; White G
    Arch Pathol Lab Med; 2004 Feb; 128(2):181-6. PubMed ID: 14736286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases.
    Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S
    Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmacytic hyperplasia--the early form of posttransplant lymphoproliferative disorder--with atypical morphology and clinical course in patient after liver transplantation: a case report.
    Ziarkiewicz-Wróblewska B; Górnicka B; Ołdakowska U; Suleiman W; Pratnicki A; Szymańska-Giemza O; Ziołkowski J; Senatorski G; Pacholczyk M; Łagiewska B; Rowiński W; Paczek L; Wasiutyński A
    Transplant Proc; 2003 Sep; 35(6):2320-2. PubMed ID: 14529928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttransplant lymphoproliferative disorder: morphological picture and diagnostic difficulties.
    Ziarkiewicz-Wróblewska B; Górnicka B; Suleiman W; Ołdakowska-Jedynak U; Wróblewski T; Bogdańska M; Ziółkowski J; Nowacka-Cieciura E; Foroncewicz B; Pileri SA; Durlik M; Paczek L; Krawczyk M; Wasiutyński A
    Transplant Proc; 2006; 38(1):168-72. PubMed ID: 16504694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders.
    Knowles DM; Cesarman E; Chadburn A; Frizzera G; Chen J; Rose EA; Michler RE
    Blood; 1995 Jan; 85(2):552-65. PubMed ID: 7812011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posttransplant lymphoproliferative disease after cardiac transplantation. Two unusual variants with predominantly plasmacytoid features.
    Fischer T; Miller M; Bott-Silverman C; Lichtin A
    Transplantation; 1996 Dec; 62(11):1687-90. PubMed ID: 8970632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmacytic post-transplant lymphoproliferative disorder: a case series of nine patients.
    Karuturi M; Shah N; Frank D; Fasan O; Reshef R; Ahya VN; Bromberg M; Faust T; Goral S; Schuster SJ; Stadtmauer EA; Tsai DE
    Transpl Int; 2013 Jun; 26(6):616-22. PubMed ID: 23551167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies.
    Meehan SM; Domer P; Josephson M; Donoghue M; Sadhu A; Ho LT; Aronson AJ; Thistlethwaite JR; Haas M
    Hum Pathol; 2001 Feb; 32(2):205-15. PubMed ID: 11230708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine needle aspiration biopsy of a posttransplant lymphoproliferative disorder with pronounced plasmacytic differentiation presenting in the face. A case report.
    Ponder TB; Collins BT; Bee CS; Grosso LE; Dunphy CH
    Acta Cytol; 2002; 46(2):389-94. PubMed ID: 11917591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The morphologic and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevant.
    Chadburn A; Chen JM; Hsu DT; Frizzera G; Cesarman E; Garrett TJ; Mears JG; Zangwill SD; Addonizio LJ; Michler RE; Knowles DM
    Cancer; 1998 May; 82(10):1978-87. PubMed ID: 9587133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete absence of KSHV/HHV-8 in posttransplant lymphoproliferative disorders: an immunohistochemical and molecular study of 52 cases.
    Chen W; Huang Q; Zuppan CW; Rowsell EH; Cao JD; Weiss LM; Wang J
    Am J Clin Pathol; 2009 May; 131(5):632-9. PubMed ID: 19369621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe cold agglutinin disease caused by recurrent monomorphic Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disorder (PTLD), clonally related to an EBV-negative plasmacytic hyperplasia in a pediatric multivisceral organ transplant recipient.
    Brunner B; Kropshofer G; Ellemunter H; Brunner A; Mueller T; Margreiter R; Tzankov A
    Pediatr Transplant; 2007 Aug; 11(5):547-51. PubMed ID: 17631026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hodgkin lymphoma-like posttransplant lymphoproliferative disorder (HL-like PTLD) simulates monomorphic B-cell PTLD both clinically and pathologically.
    Pitman SD; Huang Q; Zuppan CW; Rowsell EH; Cao JD; Berdeja JG; Weiss LM; Wang J
    Am J Surg Pathol; 2006 Apr; 30(4):470-6. PubMed ID: 16625093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal and morphological variation in a posttransplant lymphoproliferative disorder: evolution from clonal T-cell to clonal B-cell predominance.
    Nelson BP; Locker J; Nalesnik MA; Fung JJ; Swerdlow SH
    Hum Pathol; 1998 Apr; 29(4):416-21. PubMed ID: 9563796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttransplant lymphoproliferative disorders in lung transplant patients: the Cleveland Clinic experience.
    Ramalingam P; Rybicki L; Smith MD; Abrahams NA; Tubbs RR; Pettay J; Farver CF; Hsi ED
    Mod Pathol; 2002 Jun; 15(6):647-56. PubMed ID: 12065779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cell posttransplant lymphoproliferative disorders in heart and/or lungs recipients: clinical and molecular-histogenetic study of 17 cases from a single institution.
    Lucioni M; Capello D; Riboni R; Ippoliti G; Campana C; Bandiera L; Arcaini L; Rossi D; Cerri M; Dionigi P; Lazzarino M; Magrini U; Viganò M; Gaidano G; Paulli M
    Transplantation; 2006 Oct; 82(8):1013-23. PubMed ID: 17060848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EBV-positive extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in the posttransplant setting: a distinct type of posttransplant lymphoproliferative disorder?
    Gibson SE; Swerdlow SH; Craig FE; Surti U; Cook JR; Nalesnik MA; Lowe C; Wood KM; Bacon CM
    Am J Surg Pathol; 2011 Jun; 35(6):807-15. PubMed ID: 21552113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of the posttransplant lymphoproliferative disorders: from the past to the present.
    Swerdlow SH
    Semin Diagn Pathol; 1997 Feb; 14(1):2-7. PubMed ID: 9044504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.